Hear: How Are States Spending Cash From the Opioid Settlements? It’s Not Simple to Know
Opioid painkillers have left millions of Americans addicted or dead over the past three decades. Now, state and local governments are receiving more than $50 billion in settlement funds from the companies accused of aggressively promoting those medications. Many people see the money, which will be distributed over the next 15 years, as an opportunity to transform the country’s addiction treatment landscape.
But many states aren’t being transparent about where dollars are going, and others are facing contentious battles over what should be funded. Although most of the settlements require states to spend the bulk of the money on addiction treatment and prevention, defining those concepts often depends on geography and politics.
KFF Health News senior correspondent Aneri Pattani appeared on NPR’s “1A” on May 1 to discuss these critical issues and what people need to know to hold their governments accountable. She’s joined by three people featured in her previous reporting: Jackie Lewis, a mother and grandmother personally affected by the opioid epidemic; Christine Minhee, founder of OpioidSettlementTracker.com; and Cara Poland, an addiction medicine doctor and chair of Michigan’s Opioid Advisory Commission.
KFF Health News is a national newsroom that produces in-depth journalism about health issues and is one of the core operating programs at KFF—an independent source of health policy research, polling, and journalism. Learn more about KFF.
USE OUR CONTENT
This story can be republished for free (details).
We encourage organizations to republish our content, free of charge. Here’s what we ask:
You must credit us as the original publisher, with a hyperlink to our kffhealthnews.org site. If possible, please include the original author(s) and KFF Health News” in the byline. Please preserve the hyperlinks in the story.
It’s important to note, not everything on kffhealthnews.org is available for republishing. If a story is labeled “All Rights Reserved,” we cannot grant permission to republish that item.
Have questions? Let us know at KHNHelp@kff.org